V1 sact_regimen
Column details, descriptions, and lookup mappings
| # | Column | Description | Null % | Sample Values | Lookup |
|---|---|---|---|---|---|
| 1 | MERGED_REGIMEN_ID | — | — | 20114625 20114635 20114643 20114646 20114649 +5 more | — |
| 2 | MERGED_TUMOUR_ID | — | — | 10000018 10000033 10000041 10000044 10005665 +5 more | — |
| 3 | HEIGHT_AT_START_OF_REGIMEN | — | — | 1.87 1.68 1.81 162 1.73 +5 more | — |
| 4 | WEIGHT_AT_START_OF_REGIMEN | — | — | 61.5 83.6 92.1 72.2 77.2 +5 more | — |
| 5 | INTENT_OF_TREATMENT | — | — | P N 3 R 5 +5 more | — |
| 6 | DATE_DECISION_TO_TREAT | — | — | 2017-04-11 2018-07-27 2016-08-23 2018-02-20 2014-05-29 +5 more | — |
| 7 | START_DATE_OF_REGIMEN | — | — | 2016-05-17 2013-06-20 2016-09-30 2016-12-02 2014-12-31 +5 more | — |
| 8 | MAPPED_REGIMEN | — | — | PEMBROLIZUMAB Carboplatin + Vinorelbine Oral Pemetrexed + CISPLATIN Gefitinib: Cycle 3 only (PAS) CISPLATIN + ETOPOSIDE +5 more | — |
| 9 | CLINICAL_TRIAL | — | — | Y NO 2 99 1 +5 more | — |
| 10 | CHEMO_RADIATION | — | — | Y 0 1 n 2 +3 more | — |
| 11 | MERGED_PATIENT_ID | — | — | 10019936 10143111 10406386 10441112 10446112 +5 more | — |
| 12 | BENCHMARK_GROUP | — | — | DOCETAXEL DOCETAXEL + PERTUZUMAB + TRASTUZUMAB DOCETAXEL + TRASTUZUMAB PERTUZUMAB + TRASTUZUMAB TAC +5 more | — |